tislelizumab,sirexatamab,dkn-01,trastuzumab deruxtecan,atezolizumab
leap therapeutics,daiichi sankyo,astrazeneca,beigene,roche,novartis
['distinguish', 'waking', 'tislelizumab', 'gastric', 'dkn-01', 'atezo', 'roche,(-broche),(-rocheter)', 'leaptherap', 'beigene', 'leap therap']
check out our posters on dkn-01 gastric cancer clinical trials from #esmo22. distinguish: in combination with s tislelizumab and chemo in 1l. waking: in combination with s atezolizumab in 2l/3l. 
Leap Therapeutics is developing novel cancer drugs.